ABSI vs IDXX · rev $533.0K vs P/E 40, rev $2.36B
Absci Corp (ABSI) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Absci Corp (ABSI) is a biotechnology company listed on NASDAQ.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ABSI revenue for 2026-06-30 was $533.0K. Net income was -$62.8M. ABSI currently screens at market cap $1.13B.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ABSI currently screens at market cap $1.13B. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ABSI and IDXX stock pages for the full models.
Not investment advice.